Please login to the form below

Not currently logged in
Email:
Password:

Tonix names chief medical officer

Gregory Sullivan is experience academic in psychiatry

The clinical-stage specialty pharma company Tonix Pharmaceuticals has named Dr Gregory Sullivan as its first chief medical officer.

Dr Sullivan, an experienced psychiatrist and researcher, will oversee medical aspects of the New York headquartered company's clinical research and development programme, which is focused on developing treatments for diseases of the central nervous system.

It is the second senior clinical appointment that Tonix has made this year following the hire of Dr Donald Kellerman as senior VP, clinical development and regulatory affairs.

Tonix is bulking up its research team as it anticipates the first trial involving lead candidate TNX-102 SL in fibromyalgia. The drug is also in a more advanced stage of research for post-traumatic stress disorder (PTSD).

Dr Sullivan has enjoyed an extensive clinical career including experience as an assistant Professor of Psychiatry in the Department of Psychiatry at Columbia University Medical Center, a research scientist at the New York State Psychiatric Institute (NYSPI), and as a practicing psychiatrist.

His expertise includes PTSD and has been involved in several studies into the condition. He has also served on the scientific advisory board at Tonix since 2010.

"It is my hope that my medical expertise and scientific background will contribute to the successful development of this promising pipeline of novel therapeutic candidates to bring much needed treatment options to patients suffering with these challenging conditions,” said Dr Sullivan.

4th June 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...